ID: ALA271295

Max Phase: Preclinical

Molecular Formula: C29H38N2O3

Molecular Weight: 462.63

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CN(C)CCCOc1ccc(/C=C2\CC/C(=C\c3ccc(OCCCN(C)C)cc3)C2=O)cc1

Standard InChI:  InChI=1S/C29H38N2O3/c1-30(2)17-5-19-33-27-13-7-23(8-14-27)21-25-11-12-26(29(25)32)22-24-9-15-28(16-10-24)34-20-6-18-31(3)4/h7-10,13-16,21-22H,5-6,11-12,17-20H2,1-4H3/b25-21+,26-22+

Standard InChI Key:  AKERQZTUCNLYPR-CDTUYSNOSA-N

Associated Targets(Human)

CNE 323 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

HL-60 67320 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

NCI-H460 60772 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

11-beta-hydroxysteroid dehydrogenase 1 5910 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

11-beta-hydroxysteroid dehydrogenase 2 1168 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

J774.A1 2436 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

11-beta-hydroxysteroid dehydrogenase 1 202 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

11-beta-hydroxysteroid dehydrogenase 2 82 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 462.63Molecular Weight (Monoisotopic): 462.2882AlogP: 5.18#Rotatable Bonds: 12
Polar Surface Area: 42.01Molecular Species: BASEHBA: 5HBD: 0
#RO5 Violations: 1HBA (Lipinski): 5HBD (Lipinski): 0#RO5 Violations (Lipinski): 1
CX Acidic pKa: CX Basic pKa: 9.56CX LogP: 4.99CX LogD: 1.29
Aromatic Rings: 2Heavy Atoms: 34QED Weighted: 0.32Np Likeness Score: -0.40

References

1. Liang G, Li X, Chen L, Yang S, Wu X, Studer E, Gurley E, Hylemon PB, Ye F, Li Y, Zhou H..  (2008)  Synthesis and anti-inflammatory activities of mono-carbonyl analogues of curcumin.,  18  (4): [PMID:18234497] [10.1016/j.bmcl.2007.12.068]
2. Liang G, Shao L, Wang Y, Zhao C, Chu Y, Xiao J, Zhao Y, Li X, Yang S..  (2009)  Exploration and synthesis of curcumin analogues with improved structural stability both in vitro and in vivo as cytotoxic agents.,  17  (6): [PMID:19243951] [10.1016/j.bmc.2008.10.044]
3. Wang Y, Xiao J, Zhou H, Yang S, Wu X, Jiang C, Zhao Y, Liang D, Li X, Liang G..  (2011)  A novel monocarbonyl analogue of curcumin, (1E,4E)-1,5-bis(2,3-dimethoxyphenyl)penta-1,4-dien-3-one, induced cancer cell H460 apoptosis via activation of endoplasmic reticulum stress signaling pathway.,  54  (11): [PMID:21504179] [10.1021/jm200017g]
4. Lin H, Hu GX, Guo J, Ge Y, Liang G, Lian QQ, Chu Y, Yuan X, Huang P, Ge RS..  (2013)  Mono-carbonyl curcumin analogues as 11β-hydroxysteroid dehydrogenase 1 inhibitors.,  23  (15): [PMID:23800686] [10.1016/j.bmcl.2013.05.080]

Source